Literature DB >> 22906111

A possible mechanism for Inv22-related F8 large deletions in severe hemophilia A patients with high responding factor VIII inhibitors.

J Fujita1, Y Miyawaki, A Suzuki, A Maki, E Okuyama, M Murata, A Takagi, T Murate, N Suzuki, T Matsushita, H Saito, T Kojima.   

Abstract

BACKGROUND: Intron 22 inversion (Inv22) of the coagulation factor (F)VIII gene (F8) is a frequent cause of severe hemophilia A. In addition to Inv22, a variety of F8 mutations (1492 unique mutations) causing hemophilia A have been reported, of which 171 involve deletions of over 50 bp (HAMSTeRs database; http://hadb.org.uk/). However, only 10% of these large deletions have been fully characterized at the nucleotide level. PATIENTS AND METHODS: We investigated gene abnormalities in three unrelated severe hemophilia A patients with high titer FVIII inhibitors. They had previously been shown to carry large deletions of the F8, but the precise gene abnormalities remain to be elucidated.
RESULTS: Inverse shifting-PCR (IS-PCR) Inv22 diagnostic tests revealed that these patients carried either type I or II Inv22. However, they showed a wild-type (WT) pattern in the IS-PCR Inv22 complementary tests. We further analyzed their X chromosomes to account for the puzzling results, and found that they had different centromeric breakpoints in the Inv22 X chromosomes, adjacent to the palindromic regions containing int22h-2 or -3, and their spacer region, respectively. The connections appeared to be shifted towards the telomere of the WT F8 Xq28, resulting in a new telomere with an additional intact int22h copy.
CONCLUSIONS: These gene rearrangements might result from double-strand breaks in the most distal regions of the long arms of the Inv22 X chromosomes, followed by DNA restorations using the WT F8 Xq28 by non-homologous end joining or break-induced replication; thus leading to large F8 deletions in severe hemophilia A patients.
© 2012 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22906111     DOI: 10.1111/j.1538-7836.2012.04897.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  5 in total

1.  Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative.

Authors:  Jill M Johnsen; Shelley N Fletcher; Haley Huston; Sarah Roberge; Beth K Martin; Martin Kircher; Neil C Josephson; Jay Shendure; Sarah Ruuska; Marion A Koerper; Jaime Morales; Glenn F Pierce; Diane J Aschman; Barbara A Konkle
Journal:  Blood Adv       Date:  2017-05-18

2.  Validation and genotyping of multiple human polymorphic inversions mediated by inverted repeats reveals a high degree of recurrence.

Authors:  Cristina Aguado; Magdalena Gayà-Vidal; Sergi Villatoro; Meritxell Oliva; David Izquierdo; Carla Giner-Delgado; Víctor Montalvo; Judit García-González; Alexander Martínez-Fundichely; Laia Capilla; Aurora Ruiz-Herrera; Xavier Estivill; Marta Puig; Mario Cáceres
Journal:  PLoS Genet       Date:  2014-03-20       Impact factor: 5.917

3.  Phenotype and genotype of FXIII deficiency in two unrelated probands: identification of a novel F13A1 large deletion mediated by complex rearrangement.

Authors:  Siyu Ma; Changming Chen; Qian Liang; Xi Wu; Xuefeng Wang; Wenman Wu; Yan Liu; Qiulan Ding
Journal:  Orphanet J Rare Dis       Date:  2019-07-24       Impact factor: 4.123

4.  Aberrant X chromosomal rearrangement through multi-step template switching during sister chromatid formation in a patient with severe hemophilia A.

Authors:  Mahiru Tokoro; Shogo Tamura; Nobuaki Suzuki; Misaki Kakihara; Yuna Hattori; Koya Odaira; Sachiko Suzuki; Akira Takagi; Akira Katsumi; Fumihiko Hayakawa; Shuichi Okamoto; Atsuo Suzuki; Takeshi Kanematsu; Tadashi Matsushita; Tetsuhito Kojima
Journal:  Mol Genet Genomic Med       Date:  2020-07-05       Impact factor: 2.183

5.  Deletion of FUNDC2 and CMC4 on Chromosome Xq28 Is Sufficient to Cause Hypergonadotropic Hypogonadism in Men.

Authors:  Xinxian Deng; He Fang; Asha Pathak; Angela M Zou; Whitney Neufeld-Kaiser; Emily A Malouf; Richard A Failor; Fuki M Hisama; Yajuan J Liu
Journal:  Front Genet       Date:  2020-09-22       Impact factor: 4.599

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.